VRAY has been on a downtrend this whole year however there has been significant buying activity lately. The weekly MACD is about to turn bullish while the RSI has just had a higher low and is trying to come out of oversold territory. Currently VRAY is close to its 52 week low price. There has been large buying activity from the insiders, CEO, CSO (chief scientific officer)as well as institutions. This can be seen here money.cnn.com/quote/shareholders/shareholders.html?symb=VRAY&subView=insider
Their net revenue has almost doubled every year from 2015 to 2018 and the EPS (Earnings per share) is increasing steadily. The health industry is an ever growing industry and Viewray provides cutting edge MRI technology.
The earnings are coming up on November 13. Expecting the price to go up in the coming months.
*Note: This is not financial advise. Please do your own research.
Trade ativo
⋅
Hitting resistance of 3.30. Breaking that will boost the price quickly.